Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-24 @ 10:08 PM
NCT ID:
NCT02167035
Eligibility Criteria:
Inclusion Criteria:
* Open-angle glaucoma or ocular Hypertension
* Currently treated with Latanoprost for min of 6 weeks
* Male or Female 18 yrs and older
* Best Corrected Visual Acuity 20/100 or better in both eyes
* Pachymetry \>470 and \< 640
* Women of childbearing potential must have a negative urine pregnancy test at the screening/baseline visit
* Patient willing and capable of providing informed consent
Exclusion Criteria:
* C/D \> 0.8
* Visual field loss, which in the opinion of the investigator is functionally significant
* Current use of ocular steroids
* Concurrent significant active ocular disease History (within 3 months prior to Screening) of ocular laser, intraocular, filtering or refractive surgery or planned ocular surgery of any kind during study participation
* Change within prior 30 days or anticipated change in any systemic medication that is known to affect IOP
* Uncontrolled systemic disease
* Significant ocular hyperemia at baseline
* Prior glaucoma procedure within 3 months
* Females who are pregnant, nursing, or planning a pregnancy or who are of childbearing potential and not using a reliable method of contraception
* Known allergy or sensitivity to any study medication
* Asthma or any other known medical condition that the investigator feels would put patient at increased risk from any of the study medications
* Current enrollment in an investigational drug or device study or participation in such a study within 30 days prior to Screening
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02167035
Study Brief:
Protocol Section:
NCT02167035